Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Eli Lilly announced positive result on Thursday of its phase-3 clinical trails (QWINT-2 and QWINT-4) for its weekly insulin efsitora. Trial results showed that the long-acting insulin was just as ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...

Just days after Eli Lilly announced plans to ... The discount affects several of its older long- and short-acting insulin brands in both vial and pre-filled pen formats, including Levemir and ...

Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

Insulin was not a cure, but when used properly and combined with constant monitoring of diet and blood sugar, diabetics could now live long and active lives. Grinding pancreases for insulin at Eli ...

Here's what you need to know: The price of insulin has been ... month's supply of injector pens may still cost more than $150 ...

Some diabetes patients this year have had trouble finding their preferred insulin ... to short-acting insulin. Which insulin brands are in shortage and why? Earlier this year, Eli Lilly reported ...

There are many different types of insulin available in the U.S. that vary in how quickly they work, when they peak and how long their effects last. Your doctor may prescribe a combination of ...

"I thought: No insulin? Death is imminent," Wright said. Three drug companies dominate the U.S. insulin market: Novo Nordisk, ...

"I thought: No insulin? Death is imminent," Wright said. Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi ... diabetes need short-acting insulin.